![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 16/18 | (2006.01) |
A61K 39/395 | (2006.01) | ||
A61P 7/00 | (2006.01) | ||
A61P 7/06 | (2006.01) | ||
A61P 9/10 | (2006.01) | ||
A61P 13/12 | (2006.01) | ||
A61P 17/00 | (2006.01) | ||
A61P 19/02 | (2006.01) | ||
A61P 25/00 | (2006.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 31/04 | (2006.01) | ||
A61P 37/06 | (2006.01) | ||
A61P 43/00 | (2006.01) |
(11) | Number of the document | 3725803 |
(13) | Kind of document | T |
(96) | European patent application number | 20165165.0 |
Date of filing the European patent application | 2014-05-22 | |
(97) | Date of publication of the European application | 2020-10-21 |
(45) | Date of publication and mention of the grant of the patent | 2021-12-15 |
(46) | Date of publication of the claims translation | 2022-03-10 |
(30) | Number | Date | Country code |
13168941 | 2013-05-23 | EP |
(72) |
HACK, Cornelis Erik , NL
YILDIZ, Cafer , NL
BOON, Louis , NL
SIMONS, Petrus Johannes , NL
|
(73) |
Broteio Pharma B.V. ,
Yalelaan 46, 3584 CM Utrecht,
NL
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Surišančios molekulės, kurios suriša žmogaus komplemento faktorių C2b, ir jų panaudojimas |
BINDING MOLECULES THAT BIND HUMAN COMPLEMENT FACTOR C2B AND USES THEREOF |
Payment date | Validity (years) | Amount | |
2025-04-23 | 12 | 289.00 EUR |
2026-05-22 |